Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 44, 2020 - Issue 5
80
Views
4
CrossRef citations to date
0
Altmetric
Short Communications

Fifteen Cases of Hb J-Meerut: The Rare Association with Hb E and/or HBA1: c.-24C>G (or HBA2) Variants

ORCID Icon, , , &
Pages 364-367 | Received 17 Jul 2020, Accepted 21 Aug 2020, Published online: 14 Sep 2020

References

  • Blackwell RQ, Wong HB, Wang CL, et al. Hemoglobin J-Meerut: alpha120 Ala leads to Glu. Biochim Biophys Acta. 1974;351(1):7–12.
  • Kamuzora H, Lehmann H, Griffiths KD, et al. A new hemoglobin variant hemoglobin J Birmingham α120 (H3) Ala-Glu. Ann Clin Biochem. 1974;11(1–6):53–55.
  • Molchanova TP, Pobedimskaya DD, Huisman THJ. The differences in quantities of alpha2- and alpha1-globin gene variants in heterozygotes. Br J Haematol. 1994;88(2):300–306.
  • Harano T, Harano K, Imai K, et al. Hb J-Meerut [α120(H3)Ala>Glu] in a Japanese family. Hemoglobin. 1989;13(2):169–175.
  • Yalçin A, Avcu F, Beyan C, et al. A case of Hb J-Meerut (or Hb J-Birmingham) [α120(H3)Ala>Glu]. Hemoglobin. 1994;18(6):433–435.
  • Srinivas U, Mahapatra M, Pati HP. Hb J Meerut, a fast-moving hemoglobin: a study of seven cases from India and a review of literature. Am J Hematol. 2007;82(7):666–667.
  • Dinçol G, Güvenç S, Elam D, et al. Hb J-Meerut [α120(H3)Ala-Glu (α1)] in a Turkish male. Int J Med Sci. 2006;3(1):26–27.
  • Chandra D, Tyagi S, Deka R, et al. A novel double heterozygous Hb D-Punjab/Hb J-Meerut hemoglobinopathy. Indian J Hematol Blood Transfus. 2017;33(4):611–613.
  • Yagame M, Jinde K, Suzuki D, et al. A diabetic case with hemoglobin J-Meerut and low HbA1C levels. Intern Med. 1997;36(5):351–356.
  • Sharma A, Marwah S, Buxi G, et al. Falsely low HbA1c value due to a rare hemoglobin variant (HEMOGLOBIN J-MEERUT) – a family study. Indian J Pathol Microbiol. 2012;55(2):270–271.
  • Giordano PC, Maatman RG, Niessen RW, et al. Beta thalassemia IVS-I-5(G>C) heterozygosity masked by the presence of HbJ-Meerut in a Dutch–Indian patient. Haematologica. 2006;91(12 Suppl):ECR56.
  • Basset P, Beuzard Y, Garel MC, et al. Isolectric focusing of human hemoglobin: its application to screening, to the characterization of 70 variants, and to the study of modified fractions of normal hemoglobins. Blood. 1978;51(5):971–982.
  • Khalil MS, Timbs A, Henderson S, et al. Haemoglobin (Hb) G-Philadelphia, Hb Stanleyville-II, Hb G-Norfolk, Hb Matsue-Oki and Hb Mizushi can form a panel of α-chain variants that overlap in their phenotype: the novel use of StyI to screen for Hb G-Philadelphia. Int J Lab Hematol. 2011;33(3):318–325.
  • Khalil MSM, Timbs AT, Henderson SJ, et al. A wide spectrum study of α-globin chain variants: cases from the UK. Hemoglobin. 2020;44(3):195–200.
  • Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;32(Database issue):D537–D541 (http://globin.cse.psu.edu).
  • Giardine B, Borg J, Viennas E, et al. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2014;42(Database issue):D1063–D1069 (http://globin.cse.psu.edu).
  • Mutreja D, Tyagi S, Tejwani N, et al. Double heterozygous hemoglobin Q India/hemoglobin D Punjab hemoglobinopathy: report of two rare cases. Indian J Hum Genet. 2013;19(4):479–482.
  • Nair S, Nadkarni S, Warang P, et al. Five alpha globin chain variants identified during screening for haemoglobinopathies. Eur J Clin Invest. 2010;40(3):226–232.
  • Fucharoen S. Hemoglobin E disorders. In: Steinberg MH, Forget BG, Higgs DR, et al, editors. Disorders of Hemoglobin Genetics, Pathophysiology, and Clinical Management. Cambridge (NY, USA): Cambridge University Press; 2001. p. 1139–1154.
  • Joutovsky A, Hadzi-Nesic J, Nardi MA. HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory. Clin. Chem. 2004;50(10):1736–1747.
  • Szuberski J, Oliveira JL, Hoyer JD. A comprehend sive analysis of hemoglobin variants by high-performance liquid chromatography (HPLC). Int J Lab Hematol. 2012;34(6):594–604.
  • Ansari SH, Shamsi TS, Munzir S, et al. Gγ-Xmn I polymorphism: a significant determinant of β-thalassemia treatment without blood transfusion. J Pediatr Hematol Oncol. 2013;35(4):e153–e156.
  • Motovali-Bashi M, Ghasemi T. Role of XmnIγG polymorphism in hydroxyurea treatment and fetal hemoglobin level at Isfahanian intermediate β-thalassemia patients. Iran Biomed J. 2015;19(3):177–182.
  • Nguyen TKT, Joly P, Bardel C, et al. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients. Blood Cells Mol Dis. 2010;45(2):124–127.
  • Lacerra G, Fiorito M, Musollino G, et al. Sequence variations of the alpha-globin genes: scanning of high CG content genes with DHPLC and DG-DGGE. Hum Mutat. 2004;24(4):338–349.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.